Injection site vasculitis in a patient receiving interferon alfa for chronic hepatitis C.
Christian
M M
MM
Department of Dermatology, University of Texas Medical Branch at Galveston 77555-0783, USA.
Diven
D G
DG
Sanchez
R L
RL
Soloway
R D
RD
D000368:Aged; D003875:Drug Eruptions / Q000473:pathology; D005260:Female; D006526:Hepatitis C / Q000628:therapy*; D006801:Humans; D007279:Injections, Subcutaneous; D016898:Interferon-alpha / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D012867:Skin / Q000473:pathology; D017445:Skin Diseases, Vascular / Q000139:chemically induced* / Q000473:pathology; D014657:Vasculitis / Q000139:chemically induced* / Q000473:pathology
D016898:Interferon-alpha